Paper42565679
Methylene blue versus hydroxocobalamin for septic shock: a real-world comparative effectiveness study using TriNetX.
Pei Le J and 9 others. Proc (Bayl Univ Med Cent), 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Methylene blue versus hydroxocobalamin for septic shock: a real-world comparative effectiveness study using TriNetX. Papers, record 42565679. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42565679
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Methylene blue versus hydroxocobalamin for septic shock: a real-world comparative effectiveness study using TriNetX.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Methylene Blue | Major topic |
| Shock, Septic | Major topic |
| Hydroxocobalamin | Major topic |
| Humans | |
| Retrospective Studies | |
| Female | |
| Male | |
| Aged | |
| Middle Aged | |
| Treatment Outcome |
Source PubMed
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27852320 | A complex endeavour: an ethnographic study of the implementation of the Sepsis Six clinical care bundle. | Implement Sci | 2016 | https://conductscience.org/library/papers/27852320 | PubMed |
| 2 | 36174744 | High-Dose IV Hydroxocobalamin (Vitamin B12) in Septic Shock: A Double-Blind, Allocation-Concealed, Placebo-Controlled Single-Center Pilot Randomized Controlled Trial (The Intravenous Hydroxocobalamin in Septic Shock Trial). | Chest | 2023 | https://conductscience.org/library/papers/36174744 | PubMed |
| 3 | 21036796 | The sepsis six and the severe sepsis resuscitation bundle: a prospective observational cohort study. | Emerg Med J | 2011 | https://conductscience.org/library/papers/21036796 | PubMed |
| 4 | 40466258 | Vasoplegia Syndrome After Cardiac Surgery: Insights Into Mechanisms and Treatment. | JACC Heart Fail | 2025 | https://conductscience.org/library/papers/40466258 | PubMed |
| 5 | 26903336 | Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). | JAMA | 2016 | https://conductscience.org/library/papers/26903336 | PubMed |
| 6 | 39574288 | Methylene Blue for Septic Shock: A Systematic Review and Meta-analysis of Randomized and Prospective Observational Studies. | J Intensive Care Med | 2026 | https://conductscience.org/library/papers/39574288 | PubMed |
| 7 | 36237547 | Efficacy and safety of methylene blue in patients with vasodilatory shock: A systematic review and meta-analysis. | Front Med (Lausanne) | 2022 | https://conductscience.org/library/papers/36237547 | PubMed |
| 8 | 40157894 | Vasoplegic Syndrome in Cardiac Surgery: A Narrative Review of Etiologic Mechanisms and Therapeutic Options. | J Cardiothorac Vasc Anesth | 2025 | https://conductscience.org/library/papers/40157894 | PubMed |
| 9 | 36233404 | Vasoplegic Syndrome after Cardiac Surgery for Infective Endocarditis. | J Clin Med | 2022 | https://conductscience.org/library/papers/36233404 | PubMed |
| 10 | 38698779 | Methylene blue in sepsis and septic shock: a systematic review and meta-analysis. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/38698779 | PubMed |
| 11 | 31346957 | Vitamin B12 for the treatment of vasoplegia in cardiac surgery and liver transplantation: a narrative review of cases and potential biochemical mechanisms. | Can J Anaesth | 2019 | https://conductscience.org/library/papers/31346957 | PubMed |
| 12 | 36915146 | Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial. | Crit Care | 2023 | https://conductscience.org/library/papers/36915146 | PubMed |
| 13 | 38030578 | Treatment of refractory shock with vitamin B12 : A narrative review. | Nutr Clin Pract | 2024 | https://conductscience.org/library/papers/38030578 | PubMed |
| 14 | 26903338 | The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). | JAMA | 2016 | https://conductscience.org/library/papers/26903338 | PubMed |
| 15 | 31187494 | High-Dose Vitamin B12 in Vasodilatory Shock: A Narrative Review. | Nutr Clin Pract | 2019 | https://conductscience.org/library/papers/31187494 | PubMed |
| 16 | 39438181 | Hydroxocobalamin Versus Methylene Blue for Treatment of Vasoplegic Shock Following Cardiopulmonary Bypass: A Systematic Review and Meta-analysis. | J Cardiothorac Vasc Anesth | 2024 | https://conductscience.org/library/papers/39438181 | PubMed |
| 17 | 32019600 | Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options. | Crit Care | 2020 | https://conductscience.org/library/papers/32019600 | PubMed |
| 18 | 36705345 | Effect of methylene blue on hemodynamic response in the early phase of septic shock: A case series. | Medicine (Baltimore) | 2023 | https://conductscience.org/library/papers/36705345 | PubMed |
| 19 | 22534716 | Guanylate cyclase inhibition by methylene blue as an option in the treatment of vasoplegia after a severe burn. A medical hypothesis. | Med Sci Monit | 2012 | https://conductscience.org/library/papers/22534716 | PubMed |
| 20 | 37147207 | Hydroxocobalamin for Vasodilatory Hypotension in Shock: A Systematic Review With Meta-Analysis for Comparison to Methylene Blue. | J Cardiothorac Vasc Anesth | 2023 | https://conductscience.org/library/papers/37147207 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42565679
GET https://conductscience.org/api/papers/v1/42565679/references?page=2